|
1
|
Mizerska-Kowalska M, Sowa S, Donarska B, Płaziński W, Sławińska-Brych A, Tomasik A, Ziarkowska A, Łączkowski KZ, Zdzisińska B. New Borane-Protected Derivatives of α-Aminophosphonous Acid as Anti-Osteosarcoma Agents: ADME Analysis and Molecular Modeling, In Vitro Studies on Anti-Cancer Activities, and NEP Inhibition as a Possible Mechanism of Anti-Proliferative Activity. Int J Mol Sci 2022; 23:ijms23126716. [PMID: 35743158 PMCID: PMC9223658 DOI: 10.3390/ijms23126716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2022] [Revised: 06/04/2022] [Accepted: 06/14/2022] [Indexed: 11/18/2022] Open
Abstract
Many organophosphorus compounds (OPs), especially various α-aminophosphonates, exhibit anti-cancer activities. They act, among others, as inhibitors of the proteases implicated in cancerogenesis. Thesetypes of inhibitors weredescribed, e.g., for neutral endopeptidase (NEP) expressed in different cancer cells, including osteosarcoma (OS). The aim of the present study isto evaluate new borane-protected derivatives of phosphonous acid (compounds 1–7) in terms of their drug-likeness properties, anti-osteosarcoma activities in vitro (against HOS and Saos-2 cells), and use as potential NEP inhibitors. The results revealed that all tested compounds exhibited the physicochemical and ADME properties typical for small-molecule drugs. However, compound 4 did not show capability of blood–brain barrier penetration (Lipiński and Veber rules;SwissAdme tool). Moreover, the α-aminophosphonite-boranes (compounds 4–7) exhibited stronger anti-proliferative activity against OS cells than the other phosphonous acid-borane derivatives (compounds 1–3),especially regarding HOS cells (MTT assay). The most promising compounds 4 and 6 induced apoptosis through the activation of caspase 3 and/or cell cycle arrest at the G2 phase (flow cytometry). Compound 4 inhibited the migration and invasiveness of highly aggressive HOS cells (wound/transwell and BME-coated transwell assays, respectively). Additionally, compound 4 and, to a lesser extent, compound 6 inhibited NEP activity (fluorometric assay). This activity of compound 4 was involved in its anti-proliferative potential (BrdU assay). The present study shows that compound 4 can be considered a potential anti-osteosarcoma agent and a scaffold for the development of new NEP inhibitors.
Collapse
Affiliation(s)
- Magdalena Mizerska-Kowalska
- Department of Virology and Immunology, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19 Street, 20-033 Lublin, Poland; (A.T.); (A.Z.); (B.Z.)
- Correspondence:
| | - Sylwia Sowa
- Faculty of Chemistry, Department of Organic Chemistry, Maria Curie-Skłodowska University, Gliniana 33 Street, 20-614 Lublin, Poland;
| | - Beata Donarska
- Faculty of Pharmacy, Collegium Medicum, Department of Chemical Technology and Pharmaceuticals, Nicolaus Copernicus University, Jurasza 2 Street, 85-089 Bydgoszcz, Poland; (B.D.); (K.Z.Ł.)
| | - Wojciech Płaziński
- Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8 Street, 30-239 Cracow, Poland;
- Department of Biopharmacy, Faculty of Pharmacy, Medical University of Lublin, Chodźki 4A, 20-093 Lublin, Poland
| | - Adrianna Sławińska-Brych
- Department of Cell Biology, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19 Street, 20-033 Lublin, Poland;
| | - Aleksandra Tomasik
- Department of Virology and Immunology, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19 Street, 20-033 Lublin, Poland; (A.T.); (A.Z.); (B.Z.)
| | - Anna Ziarkowska
- Department of Virology and Immunology, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19 Street, 20-033 Lublin, Poland; (A.T.); (A.Z.); (B.Z.)
| | - Krzysztof Z. Łączkowski
- Faculty of Pharmacy, Collegium Medicum, Department of Chemical Technology and Pharmaceuticals, Nicolaus Copernicus University, Jurasza 2 Street, 85-089 Bydgoszcz, Poland; (B.D.); (K.Z.Ł.)
| | - Barbara Zdzisińska
- Department of Virology and Immunology, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19 Street, 20-033 Lublin, Poland; (A.T.); (A.Z.); (B.Z.)
| |
Collapse
|
|
2
|
Affiliation(s)
| | - Brian R. James
- Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada
| |
Collapse
|
|
3
|
Dietz JP, Ferenc D, Jamison TF, Gupton BF, Opatz T. Di- tert-butyl Phosphonate Route to the Antiviral Drug Tenofovir. Org Process Res Dev 2021; 25:789-798. [PMID: 37556249 PMCID: PMC7901238 DOI: 10.1021/acs.oprd.0c00473] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2020] [Indexed: 12/20/2022]
Abstract
Di-tert-butyl oxymethyl phosphonates were investigated regarding their suitability for preparing the active pharmaceutical ingredient tenofovir (PMPA). First, an efficient and simple access to the crystalline di-tert-butyl(hydroxymethyl)phosphonate was developed. O-Mesylation gave high yields of the active phosphonomethylation reagent. For the synthesis of tenofovir, a two-step sequence was developed using Mg(OtBu)2 as the base for the alkylation of (R)-9-(2-hydroxypropyl)adenine. Subsequent deprotection could be achieved with aqueous acids. (Di-tert-butoxyphosphoryl)methyl methanesulfonate showed to be the most efficient electrophile tested, affording PMPA in 72% yield on a 5 g scale. The developed protocol could also be applied for the preparation of the hepatitis B drug adefovir (64% yield/1 g scale).
Collapse
Affiliation(s)
- Jule-Philipp Dietz
- Department of Chemistry, Johannes
Gutenberg-University, Duesbergweg 10−14, Mainz 55128,
Germany
| | - Dorota Ferenc
- Department of Chemistry, Johannes
Gutenberg-University, Duesbergweg 10−14, Mainz 55128,
Germany
| | - Timothy F. Jamison
- Department of Chemistry, Massachusetts
Institute of Technology, 77 Massachusetts Avenue, Cambridge 02139,
Massachusetts, United States
| | - B. Frank Gupton
- Department of Chemical and Life Sciences Engineering,
Virginia Commonwealth University, Richmond, Virginia 23284,
United States
| | - Till Opatz
- Department of Chemistry, Johannes
Gutenberg-University, Duesbergweg 10−14, Mainz 55128,
Germany
| |
Collapse
|
|
4
|
Abstract
The P-heterocyclic field forms a special part of organophosphorus chemistry,
and is a special discipline within heterocyclic chemistry. The relevant results accumulated
in the group of the author of this minireview in last 5 years are summarized. After
surveying the conformational situation of cyclic phosphinates, their Microwave
(MW)-assisted direct esterification and the T3P®-promoted esterification are discussed.
The next chapters describe newer results regarding the interpretation and modelling of the
rate enhancing effect of MWs, and on an important, but somewhat neglected field, the
hydrolysis of phosphinates. New results on the ring enlargement of 5-membered
unsaturated P-heterocycles to 6-ring species, as well as on the synthesis of
7-phosphanorbornene derivatives, and their refunctionalization are also included. Novel
findings on the preparation of cyclic amides and imides are also explored. Last but not least, the user-friendly
deoxygenations of cyclic phosphine oxides elaborated by us are shown. The reader will be able to discover
green chemical considerations and accomplishments throughout the series of organophosphorus
transformations reviewed.
Collapse
Affiliation(s)
- György Keglevich
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, 1521 Budapest, Hungary
| |
Collapse
|